Flynn Daniel Lee
Chief Scientific Officer at Deciphera Pharmaceuticals, Inc.
- Sold, on record
- $29M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Jun 16, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Deciphera Pharmaceuticals, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualDec 10, 2019 2019
Sold 152,927 shares at $55.00 ($8.4M)
Flynn Daniel Lee, Chief Scientific Officer
Sold 86.2% of holdings ($9.8M position)24,500 shares left1x usual sizeFiling
- 2 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualDec 12, 2019 +2 days
Sold 31,029 shares at $60.00 ($1.9M)
Flynn Daniel Lee, Chief Scientific Officer
Sold 46.5% of holdings ($4M position)35,750 shares left0.2x usual sizeFiling
- 3 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedFeb 16, 2021 +432 days
Sold 508 shares at $48.87 ($25k)
Flynn Daniel Lee, Chief Scientific Officer
Sold 7.2% of holdings ($344k position)6,532 shares left0x usual sizeFiling
- 4 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedFeb 16, 2022 +365 days
Sold 1,366 shares at $9.05 ($12k)
Flynn Daniel Lee, Chief Scientific Officer
Sold 2.8% of holdings ($446k position)47,866 shares leftFiling
- 5 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedJun 16, 2022 +120 days
Sold 1,768 shares at $10.75 ($19k)
Flynn Daniel Lee, Chief Scientific Officer
Sold 3.7% of holdings ($515k position)46,098 shares leftFiling
- 6 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedJan 17, 2023 +215 days
Sold 2,403 shares at $21.24 ($51k)
Flynn Daniel Lee, Chief Scientific Officer
Sold 5.2% of holdings ($979k position)43,695 shares left1.8x usual sizeFiling
- 7 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedFeb 16, 2023 +30 days
Sold 1,370 shares at $15.10 ($21k)
Flynn Daniel Lee, Chief Scientific Officer
Sold 2.3% of holdings ($909k position)58,813 shares left0.9x usual sizeFiling
- 8 Form 4 sale Deciphera Pharmaceuticals, Inc.No planJun 16, 2023 +120 days
Sold 1,655 shares at $14.40 ($24k)
Flynn Daniel Lee, Chief Scientific Officer
No 10b5-1 planSold 2.8% of holdings ($847k position)57,158 shares left1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | Jun 21, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 1,655 | $24k | 2.8% | No plan | SEC |
| Feb 16, 2023 | Feb 17, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 1,370 | $21k | 2.3% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 2,403 | $51k | 5.2% | Plan not stated | SEC |
| Jun 16, 2022 | Jun 21, 2022 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 1,768 | $19k | 3.7% | Plan not stated | SEC |
| Feb 16, 2022 | Feb 18, 2022 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 1,366 | $12k | 2.8% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 18, 2021 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 508 | $25k | 7.2% | Plan not stated | SEC |
| Dec 12, 2019 | Dec 13, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 31,029 | $1.9M | 46.5% | Unusual | SEC |
| Dec 10, 2019 | Dec 11, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 152,927 | $8.4M | 86.2% | Unusual | SEC |
| Nov 11, 2019 | Nov 13, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 152,927 | $7.3M | 86.2% | Unusual | SEC |
| Oct 28, 2019 | Oct 30, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 29,820 | $1.2M | 54.9% | Unusual | SEC |
| Aug 13, 2019 | Aug 13, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 148,107 | $6.1M | 85.8% | Unusual | SEC |
| Jan 16, 2019 | Jan 18, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 152,629 | $4M | 100.0% | Unusual | SEC |
| Jan 11, 2019 | Jan 15, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Scientific Officer | Form 4 sale | 300 | $8k | 100.0% | Unusual | SEC |